GSK and Haleon lose billions in value as investors fear Zantac lawsuits - The Times

Investor concerns about a potential billion-dollar liability from legal proceedings related to a former GSK blockbuster drug has caused a sell-off in its shares and those of Haleon, its newly demerged consumer healthcare business. Haleon fell by more than 10 …

Billions of pounds have been wiped off the stock market values of both GSK and Haleon, the drugs groups newly demerged consumer healthcare business, amid concerns over a former GSK blockbuster drug. … [+506 chars]

full article...